Goldman Wins ASCPT Award
Jennifer Goldman, MD, Infectious Diseases, is the recipient of the Leon I. Goldberg Early Investigator Award from the American Society for Clinical Pharmacology & Therapeutics (ASCPT). She will be honored at the 2020 annual ASPCT meeting for her contributions in clinical pharmacology and translational science.
Dr. Goldman's work centers on adverse drug reactions in children and her current RO1 is focused specifically on the trimethoprim component in patients who develop an idiosyncratic drug reaction while receiving trimethoprim-sulfamethoxazole. Dr. Goldman was selected among many highly qualified candidates and this award speaks to her valuable contributions in the field of clinical pharmacology.
Children’s Mercy Kansas City is an independent, non-profit, 390-bed pediatric health system, providing over half a million patient encounters each year for children from across the country. Children’s Mercy is ranked by U.S. News & World Report in all ten specialties. We have received Magnet® recognition five times for excellence in nursing services. In affiliation with the University of Missouri-Kansas City, our faculty of nearly 800 pediatric specialists and researchers is actively involved in clinical care, pediatric research and educating the next generation of pediatricians and pediatric subspecialists. The Children’s Mercy Research Institute (CMRI) integrates research and clinical care with nationally recognized expertise in genomic medicine, precision therapeutics, population health, health care innovation and emerging infections. In 2021 the CMRI moved into a nine-story, 375,000-square-foot space emphasizing a translational approach to research in which clinicians and researchers work together to accelerate the pace of discovery that enhances care.